Fate Therapeutics
FATE
FATE
40 hedge funds and large institutions have $60.8M invested in Fate Therapeutics in 2016 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 10 increasing their positions, 13 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
40
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$11.7M | |
| 2 | +$1.43M | |
| 3 | +$1.38M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$73.1K |
| 5 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$71.6K |
Top Sellers
| 1 | -$607K | |
| 2 | -$351K | |
| 3 | -$187K | |
| 4 |
EA
Emerald Acquisition
Seattle,
Washington
|
-$143K |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$131K |